ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,328, issued on Aug. 4, was assigned to GammaDelta Therapeutics Ltd. (London).
"Antibodies" was invented by Oxana Polyakova (London), Oliver Nussbaumer (London), Adrian Hayday (London) and Pierre Vantourout (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "An isolated antibody or fragment thereof, which specifically binds to a gamma variable 4 (VGamma4) chain of a GammaDelta T cell receptor (TCR) and not to a gamma variable 2 (VGamma2) chain of a GammaDelta TCR is provided herein. Methods of treatment and other uses of said antibodies are also provided along with methods of producing said antibodies."
The patent was filed on Feb. 24, 2021, under...